MTAR Technologies Ltd Q3 FY2026 Concall Summary

Key Takeaways

• Record quarter, 59% YoY growth: Revenue hit INR278 crores, the highest ever, driven by clean energy fuel cells and a 70% surge in aerospace.
• Order book building toward INR2,800 crores: The long-awaited INR500+ crores Kaiga nuclear order landed, and clean energy inflows hit a fiscal-year high, supporting the year-end target.
• Capacity expansion is the binding constraint: Fuel cell capacity is at 100% utilization; management is racing to triple it to 30,000 units, betting on a customer forecast of ~30% growth through 2030.
• Margins dipped on mix, recovery promised: Gross margin fell to 46.1% as lower-margin fuel cells dominated the mix, but management expects operating leverage and volume production to drive a "substantial" EBITDA margin improvement in FY27.
• What to watch next quarter: Whether nuclear dispatches begin "in a big way" from Q1, the pace of the fuel cell capacity ramp to 12,000 units by March-end, and any progress on customer advances to reverse the negative operating cash flow.

Clean Energy: The Bloom Engine

• Fuel cells drove the quarter: The segment delivered its highest-ever order inflows year-to-date, and management expects Q4 clean energy revenue alone to reach INR250 crores.
• The demand signal is the customer's own growth: Bloom Energy's \$2.65 billion agreement with AEP and its projected ~30% growth through 2030, fueled by AI data centre power demand, is the anchor for MTAR's capacity bet.
• Capacity is the bottleneck, not orders: Utilization is at 100% on the current 8,000-unit line. The expansion to 12,000 units finishes by March-end, with 20,000 targeted by December and infrastructure being built for 30,000 units the following year.
• Tariff risk was deflected, not resolved: When asked about India's higher tariff rate versus competitors, management stated tariffs are "not a concern" due to technology and competitiveness, but did not address the rate differential or provide specific offtake commitments beyond the customer forecast.
• Gross margin dilution is a mix story: The 46.1% quarterly gross margin, down from 49.5% for the nine-month period, is purely due to the higher share of lower-margin fuel cells; management insists this does not drag down EBITDA.
• Non-Bloom clean energy is building: Orders from GE, Andritz, and Voith are materializing, with INR40 crores per year in hydro orders recently finalized and INR100-120 crores of executable orders targeted from these customers next year.

Srinivas Reddy: "It's not about orders, but it's about how much you can produce. That's where we are right now."

Nuclear: The Inflection Quarter

• The Kaiga order broke the logjam: MTAR received the much-anticipated INR500+ crores order for Kaiga Units 5 and 6, validating the civil nuclear thesis.
• Dispatches begin next quarter: The majority of nuclear orders are currently work-in-progress due to long gestation periods; management stated dispatches will start from Q1 of next year "in a big way," with existing orders executing in Q1-Q2 and new orders kicking in from Q3-Q4.
• The per-reactor opportunity is growing: New reactors represent an INR350-400 crores opportunity per reactor, up from INR250 crores for Kaiga, implying a richer mix ahead.
• A policy catalyst may be imminent: The government is likely to announce a PLI scheme valued at INR18,000-20,000 crores for critical nuclear component manufacturing in the upcoming union budget, though details on capital requirements remain unknown.
• Refurbishment orders are the near-term follow-on: Management expects further orders from refurbishment reactors during the current quarter and the beginning of next quarter.
• FY27 nuclear revenue is guided conservatively: The INR150 crores figure is called "conservative," with management stating it will do "much more than that," and INR300-500 crores of additional order book per year is "a very fair number."

Srinivas Reddy: "I see a huge ramp up... the number of orders which are going to kick in over the next 2, 3 years is going to be phenomenal because of the new reactors coming in and the government announcing the privatization."

Aerospace: First Articles Becoming Volume

• The division grew 70% in Q3: First articles have been completed and batch production has started for several customers, marking the transition from development to recurring revenue.
• Quarterly revenue is set to double: Once first articles convert fully to volume production, management expects aerospace revenue to jump from the current INR18-19 crores to INR40-50 crores per quarter, with a FY27 target of INR150-160 crores.
• Capacity exists for the ramp: MTAR has enough installed capacity for up to INR200 crores of aerospace business, with additional machines arriving over the next 2-3 months to push beyond that ceiling.
• The ambition is structural assembly: Management intends to progressively graduate from parts manufacturing to structural assembly orders over the coming years, and plans to establish direct relationships with Boeing and Airbus within 1 to 1.5 years.
• AMCA is a milestone, not near-term revenue: The company was declared L1 for the main landing gear test setup assembly for the AMCA program, but the program is still being assessed by ADA and will take another 2-3 months to shortlist.

Srinivas Reddy: "This is what I keep saying. What you don't see in the balance sheet is the kind of work MTAR has been doing on the background with various customers, developing various first articles, proving our capabilities... you will see the results over the next year and moving forward as well."

Operations: Cash Flow, Working Capital, and Margins

• Cash flow turned negative: Cash flow from operations was INR22 crores negative because higher revenues are sitting in receivables; management is working with customers on advance payment opportunities for Q4.
• Working capital is the near-term fix: Inventory days improved sharply from 282 to 210 as export dispatches increased, and the CFO is targeting 235 days as-is for Q4, or less than 200 days if customer advances materialize. The FY27 target is approximately 200-210 days.
• EBITDA margin recovery is promised, not quantified: FY26 average EBITDA margin is about 21%; management says FY27 will be "much higher" and margins will "substantially improve" with higher operating leverage, but declined to comment on an exact number or explicitly reaffirm the prior 28% FY28 target.
• The FY23 disruption is not expected to repeat: Management does not see a repeat of the drastic model change that impacted volumes in FY23; any future changes would be minor tweaks, and if Bloom reduces costs through design changes, MTAR's value-add and realization per unit are not expected to change.

Guidance & Commitments

Key Metrics